Azithromycin for Injection

Advantages: 1. 0.125g and 0.25g: unique production in China;2. The flagship product among macrolide antibiotics；
3. A broad-spectrum antibiotic featuring a unique Trojan horse mechanism and a long post-antibiotic effect (PAE).

Indications-This product is indicated for the following infections caused by susceptible pathogenic strains:
1. Community-acquired pneumonia caused by Chlamydia pneumoniae, Haemophilus influenzae, Legionella pneumophila, Moraxella catarrhalis, Mycoplasma pneumoniae, Staphylococcus aureus or Streptococcus pneumoniae that requires initial intravenous infusion therapy;
2. Pelvic inflammatory disease caused by Chlamydia trachomatis, Neisseria gonorrhoeae or Mycoplasma hominis that requires initial intravenous infusion therapy.